LLY Eli Lilly and Company Stock Quote

LLY [NYSE]

Healthcare | Drug Manufacturers - General | USA

Index	S&P 500	P/E	31.24	EPS (ttm)	6.11	Insider Own	11.70%	Shs Outstand	907.20M	Perf Week	14.64%
Market Cap	178.58B	Forward P/E	23.28	EPS next Y	8.19	Insider Trans	-0.40%	Shs Float	744.27M	Perf Month	13.94%
Income	5.57B	PEG	2.24	EPS next Q	2.35	Inst Own	79.20%	Short Float	0.70%	Perf Quarter	29.97%
Sales	23.21B	P/S	7.69	EPS this Y	54.10%	Inst Trans	1.53%	Short Ratio	1.22	Perf Half Y	14.95%
Book/sh	5.32	P/B	35.86	EPS next Y	8.92%	ROA	13.40%	Target Price	185.88	Perf Year	34.89%
Cash/sh	3.88	P/C	49.19	EPS next 5Y	13.97%	ROE	152.60%	52W Range	117.06 - 189.30	Perf YTD	12.99%
Dividend	3.40	P/FCF	64.14	EPS past 5Y	17.40%	ROI	24.60%	52W High	0.78%	Beta	0.34
Dividend %	1.78%	Quick Ratio	1.10	Sales past 5Y	2.60%	Gross Margin	78.30%	52W Low	62.97%	ATR	5.66
Employees	33625	Current Ratio	1.40	Sales Q/Q	4.80%	Oper. Margin	23.80%	RSI (14)	73.55	Volatility	3.50% 2.39%
Optionable	Yes	Debt/Eq	3.51	EPS Q/Q	-2.90%	Profit Margin	24.00%	Rel Volume	1.55	Prev Close	186.69
Shortable	Yes	LT Debt/Eq	3.38	Earnings	Jan 29 BMO	Payout	46.70%	Avg Volume	4.27M	Price	190.77
Recom	2.20	SMA20	11.63%	SMA50	21.91%	SMA200	24.29%	Volume	6,624,572	Change	2.19%

Dec-10-20

Upgrade

Wolfe Research

Peer Perform → Outperform

$147 → $183

Nov-10-20

Resumed

Bernstein

Mkt Perform

$150

Sep-29-20

Initiated

Berenberg

Hold

$144

Sep-03-20

Upgrade

Morgan Stanley

Equal-Weight → Overweight

$176

Jun-16-20

Upgrade

Guggenheim

Neutral → Buy

Apr-21-20

Downgrade

UBS

Buy → Neutral

$157 → $158

Apr-09-20

Downgrade

Morgan Stanley

Overweight → Equal-Weight

$148

Feb-06-20

Initiated

Mizuho

Neutral

Dec-18-19

Upgrade

Morgan Stanley

Equal-Weight → Overweight

$116 → $150

Oct-17-19

Resumed

BofA/Merrill

Buy

$133

May-28-19

Initiated

Goldman

Buy

Apr-24-19

Upgrade

Edward Jones

Hold → Buy

Apr-11-19

Downgrade

Guggenheim

Buy → Neutral

Mar-12-19

Initiated

JP Morgan

Overweight

$140

Jan-23-19

Initiated

UBS

Buy

$131

Nov-26-18

Downgrade

Citigroup

Buy → Neutral

Oct-31-18

Upgrade

Credit Suisse

Underperform → Neutral

Oct-09-18

Initiated

Guggenheim

Buy

Oct-01-18

Reiterated

SunTrust

Buy

$105 → $123

Sep-26-18

Resumed

JP Morgan

Overweight

$117

Jan-19-21 06:30AM	Lilly and Merus NV Announce Collaboration to Discover Novel T-Cell Re-Directing Bispecific Antibodies PR Newswire
Jan-15-21 05:02PM	Lilly Confirms Date and Conference Call for Fourth-Quarter 2020 Financial Results Announcement PR Newswire
08:14AM	Pharma Stock Roundup: LLY's Alzheimer Disease Data, NVS & SNY's M&A Deals Zacks
06:45AM	Lilly Announces $30 Million Limited Partner Investment in Unseen Capital Health Fund PR Newswire
Jan-14-21 03:29PM	Biogen Stock Is Jumping Because There May Be Hope for Its Alzheimers Drug Yet Barrons.com
12:28PM	The Zacks Analyst Blog Highlights: Amazon, Thermo Fisher, Eli Lilly, Google and CVS Health Zacks
06:45AM	Gabrielle Sulzberger Elected to Lilly Board of Directors PR Newswire
Jan-13-21 04:26PM	Top Analyst Reports for Amazon, Thermo Fisher & Eli Lilly Zacks
09:35AM	Diamondback Energy, Ryman Hospitality Properties, Eli Lilly, Biogen and Roche highlighted as Zacks Bull and Bear of the Day Zacks
02:41AM	Is Eli Lilly and Company (NYSE:LLY) Popular Amongst Institutions? Simply Wall St.
Jan-12-21 03:10PM	Eli Lilly Has Good News About Its Alzheimers Drug. Heres What It Means for Biogen. Barrons.com
10:25AM	Lilly's (LLY) Alzheimer's Drug Promising in Mid-Stage Study Zacks
09:32AM	Company News for Jan 12, 2021 Zacks
03:37AM	Eli Lilly Jumps After Alzheimers Drug Shows Positive Results FX Empire
Jan-11-21 05:00PM	The Dow Fell 89 Points Because Stocks Are Way Overextended Barrons.com +11.74%
04:29PM	Lilly Rockets On Alzheimer's News And 3 Other Highlights From Key Health Care Meeting Investor's Business Daily
04:19PM	Eli Lilly, Office Depot, Crocs: 5 Gainers for Monday TheStreet.com
01:00PM	Here's Why Eli Lilly Broke to the Upside TheStreet.com
12:59PM	Lillys Alzheimer's Drug Isnt Worth $20 Billion Yet Bloomberg
11:42AM	Biogen's stock is up 5% after Lilly reports positive data from an Alzheimer's study MarketWatch
10:24AM	Return On Capital Employed Overview: Eli Lilly Benzinga
09:45AM	Dow Off Lows as Energy, Healthcare Rise; Democrats Eye Trump Impeachment Investing.com
09:44AM	Eli Lilly Surges On Positive Data From Key Trial of Alzheimer's Treatment TheStreet.com
09:00AM	Why Eli Lilly Stock Is Crushing It Today Motley Fool
08:56AM	Dow Jones Today, Stocks Slump As Trump Ban Slams Twitter, Lilly Soars On Alzheimer's News, Boeing Slips After 737 Crash Investor's Business Daily
08:55AM	Eli Lilly Stock Gains as Drug Slows Decline in Alzheimers Patients Barrons.com
08:15AM	Eli Lilly, Boeing, Twitter, NIO - Monday's Premarket Movers TheStreet.com
08:00AM	US FDA accepts supplemental New Drug Application for Jardiance® (empagliflozin) for adults with heart failure with reduced ejection fraction PR Newswire
07:22AM	Lilly's stock jumps 15% after experimental Alzheimer's drug shows it can slow cognitive decline MarketWatch
06:30AM	Lilly's Donanemab Slows Clinical Decline of Alzheimer's Disease in Positive Phase 2 Trial PR Newswire
Jan-08-21 09:00AM	Don't Expect Covid-19 Research to Deliver Certainty Bloomberg
Jan-07-21 11:05AM	Radius (RDUS) to Acquire Rights for Cannabidiol Oral Solution Zacks
Jan-05-21 05:50PM	Eli Lilly (LLY) Gains But Lags Market: What You Should Know Zacks
04:02PM	Spiros Segalas' Top Trades of the 4th Quarter GuruFocus.com
10:05AM	A Look Into Eli Lilly's Price Over Earnings Benzinga
08:17AM	(PRVL Alert) Johnson Fistel Investigates Proposed Sale of Prevail; Are Shareholders Getting a Fair Deal? GlobeNewswire
06:00AM	Get Ready for Health-Care Stocks to Go Wild. How to Play Them. Barrons.com
Jan-04-21 03:30PM	Lilly to Participate in J.P. Morgan Healthcare Conference PR Newswire
10:18AM	Outlook for biotech companies in 2021 Yahoo Finance Video
Jan-03-21 04:37AM	Why Aren't Doctors Prescribing Eli Lilly's and Regeneron's COVID-19 Treatments? Motley Fool
Dec-30-20 11:34AM	Regeneron (REGN) Releases Initial Data on Cocktail for COVID-19 Zacks
09:28AM	Regenerons Antibodies Appear to Help Hospitalized Patientsand Could Help 2021 Revenue Barrons.com
Dec-29-20 05:50PM	Eli Lilly (LLY) Gains As Market Dips: What You Should Know Zacks
09:10AM	Amphastar Surges on FDA Approval of Generic Hypoglycemia Injection TheStreet.com
Dec-28-20 04:01PM	25 Safest Cities in America in 2020 Insider Monkey
Dec-23-20 05:45PM	Eli Lilly (LLY) Stock Sinks As Market Gains: What You Should Know Zacks
Dec-22-20 03:34PM	10 Best Healthcare Dividend Stocks Insider Monkey
01:27PM	(PRVL Alert) Johnson Fistel Investigates Proposed Sale of Prevail; Are Shareholders Getting a Fair Deal? PR Newswire
Dec-21-20 09:00AM	Principle LTC's Tower Nursing & Rehabilitation Center Joins with Eli Lilly and Company on Phase 3 Drug Trial for COVID-19 Prevention PR Newswire
06:27AM	Here's Why Lilly (LLY) Has Outperformed the Industry This Year Zacks
Dec-19-20 07:00AM	Eli Lilly, Amgen, and 2 Other Companies That Raised Their Dividends This Week Barrons.com
Dec-18-20 05:00PM	Lilly to begin pragmatic study of neutralizing antibody bamlanivimab (LY-CoV555) for COVID-19 in New Mexico PR Newswire
02:14PM	3 Stocks Delivering Over 10% Dividend Increases GuruFocus.com
07:34AM	Pharma Stock Roundup: FDA Emergency Nod to PFE/BNTX COVID-19 Vaccine, AZN to Buy ALXN Zacks
Dec-17-20 05:45PM	Eli Lilly (LLY) Gains But Lags Market: What You Should Know Zacks
10:04AM	The Zacks Analyst Blog Highlights: Mastercard, Eli Lilly, Citigroup, Advanced Micro Devices and Square Zacks
10:00AM	Bluebird Bio, Biomarin Tabbed as Top Acquisition Targets GuruFocus.com
Dec-16-20 08:21PM	PREVAIL THERAPEUTICS INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Prevail Therapeutics Inc. - PRVL PR Newswire
03:30PM	U.S. hospital demand for Lilly, Regeneron COVID-19 antibody drugs 'disappointing' Reuters
02:56PM	SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation of Prevail Therapeutics Inc. Buyout GlobeNewswire
02:05PM	Top Analyst Reports for Mastercard, Eli Lilly & Citigroup Zacks
12:37PM	PREVAIL THERAPEUTICS ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of PRVL and Encourages Investors to Contact the Firm GlobeNewswire
10:29AM	Lilly (LLY) to Acquire Prevail Therapeutics for Gene Therapies Zacks
09:37AM	Company News for Dec 16, 2020 Zacks
07:57AM	Lilly (LLY) Stock Up on Raised 2020 View, Upbeat 2021 Guidance Zacks
Dec-15-20 05:39PM	Christmas Came Early for Eli Lilly Shareholders GuruFocus.com +6.03%
04:36PM	This Gene Therapy Stock Is Ablaze On Eli Lilly's $1.04 Billion Takeover Investor's Business Daily
04:25PM	US STOCKS-Nasdaq ends at record high on stimulus bets, Apple boost Reuters
04:18PM	Why Eli Lilly Stock Jumped Today Motley Fool
03:15PM	Eli Lilly Acquiring Prevail Therapeutics in $880 Million Deal Motley Fool
02:37PM	US STOCKS-Stimulus optimism and Apple spark Wall Street rally Reuters
12:31PM	US STOCKS-Wall St supported by Apple, stimulus bets as Fed takes center stage Reuters
11:45AM	Why Plug Power and Prevail Therapeutics Gave the Stock Market a Boost Tuesday Morning Motley Fool
11:20AM	Why Prevail Therapeutics Stock Is Skyrocketing Today Motley Fool
11:00AM	Eli Lilly to Buy Prevail Therapeutics in $1.04 Billion Deal, Shares Soar FX Empire
10:49AM	Eli Lilly Lifts Sales Guidance, Enters Gene Therapy Field With Prevail Acquisition Benzinga
10:38AM	Eli Lilly to Buy Prevail for $1 Billion in Parkinsons Push Bloomberg
10:19AM	US STOCKS-Wall Street gains on Apple, stimulus hopes as Fed takes center stage Reuters
10:04AM	Dow Jones Rebounds, Stocks Climb On Stimulus Compromise; Baidu Looks Into EVs, Apple Boosts iPhone Output Investor's Business Daily
09:58AM	P/E Ratio Insights for Eli Lilly Benzinga
09:53AM	Eli Lilly and Company -- Moody's announces completion of a periodic review of ratings of Eli Lilly and Company Moody's
09:51AM	Return On Capital Employed Overview: Eli Lilly Benzinga
09:48AM	Lilly Sees Gains from Fighting Covid and Buys into Gene Therapy Barrons.com
09:44AM	Eli Lilly Boosts Profit Guidance, Buys Prevail Therapeutics For $1 Billion TheStreet.com
08:36AM	US STOCKS-Wall Street set to rise on stimulus hopes; Fed meet in focus Reuters
07:53AM	Eli Lilly, Prevail Therapeutics, Boeing - Tuesday's Premarket Movers TheStreet.com
06:43AM	Eli Lilly's stock rallies after raising full-year profit outlook MarketWatch
06:30AM	Lilly Announces 2021 Financial Guidance, Updates 2020 Guidance PR Newswire
06:25AM	Prevail Therapeutics stock nearly doubles after Eli Lilly buyout deal MarketWatch
06:15AM	Lilly Announces Agreement to Acquire Prevail Therapeutics PR Newswire
Dec-14-20 07:18PM	Eli Lilly Raises Dividend by 15% Motley Fool
04:12PM	Eli Lilly raises dividend by 15% MarketWatch
04:05PM	Lilly Announces 15 Percent Dividend Increase PR Newswire
11:05AM	Lilly announces opening of patient enrollment for New IDEAS: Imaging Dementia - Evidence for Amyloid Scanning study PR Newswire
Dec-13-20 03:00PM	Nike, FedEx, Lennar, Eli Lilly, and Other Stocks for Investors to Watch This Week Barrons.com
Dec-11-20 05:45PM	Eli Lilly (LLY) Dips More Than Broader Markets: What You Should Know Zacks
04:35PM	Thiel-Backed Developer of Covid-19 Therapy Surges in Debut Bloomberg
03:04PM	COVID SCIENCE-Drug combination improves COVID-19 pneumonia outcomes; five genes linked to severe disease Reuters
02:01PM	Data from ACTT-2 Trial of Baricitinib in Hospitalized COVID-19 Patients Supportive of the EUA Published in New England Journal of Medicine PR Newswire
11:00AM	Five key severe COVID-19 genes found, suggesting drug targets Reuters

Eli Lilly and Company discovers, develops, manufactures, and markets pharmaceutical products worldwide. It offers endocrinology products for diabetes; osteoporosis in postmenopausal women and men; and human growth hormone deficiency and paediatric growth conditions. The company also provides neuroscience products for treating depressive disorder, diabetic peripheral neuropathic pain, anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; migraine and episodic cluster headache; attention-deficit hyperactivity disorder; and schizophrenia. In addition, it offers immunology products for the treatment of rheumatoid arthritis, plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis; oncology products to treat non-small cell lung, colorectal, head and neck, pancreatic, metastatic breast, ovarian, bladder, and metastatic gastric cancers, as well as malignant pleural mesothelioma; and products to treat erectile dysfunction and benign prostatic hyperplasia. Eli Lilly and Company primarily has collaborations with Incyte Corporation; Pfizer Inc.; Dicerna Pharmaceuticals, Inc.; AC Immune SA; Centrexion Therapeutics Corporation; ImmuNext, Inc.; Avidity Biosciences, Inc.; Duke Clinical Research Institute for the prevention of chronic heart failure and mortality after an acute myocardial infarction; AbCellera Biologics Inc.; and Sermonix Pharmaceuticals Inc., as well as an agreement with Junshi Biosciences to co-develop therapeutic antibodies for the potential prevention and treatment of COVID-19, the disease caused by the SARS-CoV-2 novel coronavirus. The company was founded in 1876 and is headquartered in Indianapolis, Indiana.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
LILLY ENDOWMENT INC	10% Owner	Jan 13	Sale	185.97	210,000	39,053,064	110,702,343	Jan 14 11:23 AM
LILLY ENDOWMENT INC	10% Owner	Jan 11	Sale	185.49	220,000	40,807,754	110,912,343	Jan 12 11:27 AM
Smiley Joshua L	SVP and CFO	Oct 01	Option Exercise	0.00	7,947	0	44,918	Oct 05 12:19 PM
Barnes Melissa S	Chief Eth/Cmpl Ofcr & SVP, ERM	Sep 08	Sale	151.01	5,000	755,050	23,580	Sep 10 04:25 PM
Mason Michael B	Sr. VP & Pres., Lilly Diabetes	Sep 01	Option Exercise	0.00	6,244	0	21,279	Sep 02 05:04 PM
Fry Stephen F	SVP, HR & Diversity	Aug 17	Sale	150.64	7,204	1,085,211	100,211	Aug 18 03:31 PM
LILLY ENDOWMENT INC	10% Owner	Jul 09	Sale	169.69	12,961	2,199,392	111,132,343	Jul 10 02:16 PM
Zulueta Alfonso G	SVP & President, Lilly Int'l	Jul 09	Sale	170.00	11,000	1,870,000	18,646	Jul 13 01:43 PM
LILLY ENDOWMENT INC	10% Owner	Jul 07	Sale	167.29	210,000	35,131,799	111,145,304	Jul 08 12:49 PM
LILLY ENDOWMENT INC	10% Owner	Jul 06	Sale	166.99	205,000	34,232,086	111,379,612	Jul 07 02:27 PM
Pusey Leigh Ann	SVP, Corp. Affairs & Comm.	Jul 05	Option Exercise	0.00	2,468	0	5,424	Jul 06 04:50 PM
LILLY ENDOWMENT INC	10% Owner	Jun 30	Sale	163.20	166,832	27,227,760	111,560,304	Jul 01 11:17 AM
LILLY ENDOWMENT INC	10% Owner	Jun 29	Sale	163.39	11,431	1,867,760	111,727,136	Jun 30 03:12 PM
LILLY ENDOWMENT INC	10% Owner	Jun 26	Sale	163.01	31,737	5,173,404	111,738,567	Jul 01 09:55 AM
LILLY ENDOWMENT INC	10% Owner	Jun 26	Sale	163.01	31,737	5,173,404	111,738,567	Jun 30 02:48 PM
LILLY ENDOWMENT INC	10% Owner	Jun 18	Sale	161.54	53,770	8,686,046	111,770,304	Jun 19 02:21 PM
LILLY ENDOWMENT INC	10% Owner	Jun 17	Sale	161.38	161,230	26,019,469	111,824,074	Jun 18 05:16 PM
Zulueta Alfonso G	SVP & President, Lilly Int'l	Jun 16	Sale	162.94	17,000	2,770,000	29,646	Jun 18 09:36 AM
LILLY ENDOWMENT INC	10% Owner	Jun 16	Sale	162.92	212,337	34,593,145	111,985,304	Jun 17 03:13 PM
Zulueta Alfonso G	SVP & President, Lilly Int'l	Jun 05	Sale	150.00	10,000	1,500,000	46,646	Jun 09 04:52 PM
LILLY ENDOWMENT INC	10% Owner	Apr 27	Sale	163.60	12,663	2,071,715	112,197,641	Apr 28 12:21 PM
LILLY ENDOWMENT INC	10% Owner	Apr 24	Sale	162.47	220,000	35,743,218	112,210,304	Apr 27 02:36 PM
LILLY ENDOWMENT INC	10% Owner	Apr 23	Sale	160.12	230,000	36,826,587	112,430,304	Apr 27 10:39 AM
Shah Aarti S.	SVP & CIO	Apr 14	Sale	150.00	2,000	300,000	19,087	Apr 16 11:23 AM
LILLY ENDOWMENT INC	10% Owner	Apr 09	Sale	145.42	230,000	33,445,542	112,660,304	Apr 13 02:43 PM
LILLY ENDOWMENT INC	10% Owner	Apr 07	Sale	143.20	172,315	24,676,281	112,890,304	Apr 08 12:49 PM
LILLY ENDOWMENT INC	10% Owner	Apr 06	Sale	142.73	15,962	2,278,322	113,062,619	Apr 07 11:40 AM
LILLY ENDOWMENT INC	10% Owner	Apr 03	Sale	143.19	26,723	3,826,493	113,078,581	Apr 06 02:42 PM
LILLY ENDOWMENT INC	10% Owner	Apr 02	Sale	140.78	166,038	23,374,654	113,105,304	Apr 03 12:42 PM
LILLY ENDOWMENT INC	10% Owner	Mar 31	Sale	140.07	38,962	5,457,474	113,271,342	Apr 01 01:47 PM
LILLY ENDOWMENT INC	10% Owner	Mar 30	Sale	139.11	210,000	29,213,559	113,310,304	Mar 31 04:03 PM
Fry Stephen F	SVP, HR & Diversity	Mar 30	Sale	134.30	14,657	1,968,434	107,415	Mar 31 11:50 AM
Norton Johna	Senior VP, Global Quality	Mar 16	Sale	131.00	4,727	619,237	17,674	Mar 18 10:44 AM
O'Neill Myles	SVP & Pres., Mfg. Operations	Mar 04	Sale	140.15	25,000	3,503,750	8,469	Mar 06 10:46 AM
Zakrowski Donald A	Chief Accounting Officer	Mar 02	Sale	128.00	3,700	473,600	4,740	Mar 03 03:27 PM
Norton Johna	Senior VP, Global Quality	Feb 16	Option Exercise	0.00	97	0	162	Feb 18 02:57 PM
LILLY ENDOWMENT INC	10% Owner	Feb 05	Sale	146.61	200,000	29,321,808	113,520,304	Feb 06 02:27 PM
Zulueta Alfonso G	SVP & President, Lilly Int'l	Feb 01	Option Exercise	0.00	16,317	0	45,623	Feb 04 03:59 PM
Ricks David A	President & CEO	Feb 01	Option Exercise	0.00	69,350	0	226,755	Feb 04 03:54 PM
Fry Stephen F	SVP, HR & Diversity	Feb 01	Option Exercise	0.00	13,055	0	113,266	Feb 04 03:47 PM
Barnes Melissa S	Chief Eth/Cmpl Ofcr & SVP, ERM	Feb 01	Option Exercise	0.00	4,896	0	25,166	Feb 04 03:44 PM

open in yahoo | open in reuters | open in google

Upgrade your FINVIZ experience